BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1220 related articles for article (PubMed ID: 9351509)

  • 1. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
    Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
    Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of kappa opioid receptors in modulating cholinergic twitches in the circular muscle of guinea-pig colon.
    Giuliani S; Lecci A; Tramontana M; Maggi CA
    Br J Pharmacol; 1996 Nov; 119(5):985-9. PubMed ID: 8922749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
    Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
    Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
    Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat neostriatal slices.
    Schlösser B; Kudernatsch MB; Sutor B; ten Bruggencate G
    Neurosci Lett; 1995 May; 191(1-2):126-30. PubMed ID: 7659278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor selectivity of Met-enkephalin-Arg6-Phe7, an endogenous opioid peptide, in cerebral cortex of human and rat.
    Kim KW; Woo RS; Kim CJ; Cheong YP; Kim JK; Kwun J; Cho KP
    Life Sci; 2000 May; 67(1):61-71. PubMed ID: 10896030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
    Schoffelmeer AN; De Vries TJ; Hogenboom F; Hruby VJ; Portoghese PS; Mulder AH
    J Pharmacol Exp Ther; 1992 Oct; 263(1):20-4. PubMed ID: 1328606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptor-mediated inhibition of 3H-dopamine and 14C-acetylcholine release from rat nucleus accumbens slices. A study on the possible involvement of K+ channels and adenylate cyclase.
    Heijna MH; Hogenboom F; Mulder AH; Schoffelmeer AN
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):627-32. PubMed ID: 1321956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
    Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu and kappa opioid receptor modulation of 5-HT3 and NK-3 receptor-evoked release of acetylcholine from the guinea-pig ileum myenteric plexus.
    Fox AJ; Morton IK
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):8-15. PubMed ID: 1723152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids modulate the cholinergic contraction but not the nonadrenergic relaxation in guinea-pig airways in vitro.
    Pype JL; Dupont LJ; Demedts MG; Verleden GM
    Eur Respir J; 1996 Nov; 9(11):2280-5. PubMed ID: 8947072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. kappa-Opioid inhibition of [3H]dopamine release from rat ventral mesencephalic dissociated cell cultures.
    Smith JA; Loughlin SE; Leslie FM
    Mol Pharmacol; 1992 Oct; 42(4):575-83. PubMed ID: 1359395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
    Madamba SG; Schweitzer P; Siggins GR
    J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
    Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
    Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit.
    Jackisch R; Geppert M; Brenner AS; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):156-62. PubMed ID: 2871497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs.
    Werling LL; Frattali A; Portoghese PS; Takemori AE; Cox BM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):282-6. PubMed ID: 2839666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta and kappa opioid receptor subtypes and ingestion: antagonist and glucoprivic effects.
    Yu WZ; Ruegg H; Bodnar RJ
    Pharmacol Biochem Behav; 1997 Mar; 56(3):353-61. PubMed ID: 9077569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.